<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0003-3170</journal-id>
<journal-title><![CDATA[Angiología]]></journal-title>
<abbrev-journal-title><![CDATA[Angiología]]></abbrev-journal-title>
<issn>0003-3170</issn>
<publisher>
<publisher-name><![CDATA[Arán Ediciones S.L.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0003-31702023000600003</article-id>
<article-id pub-id-type="doi">10.20960/angiologia.00542</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Estudio prospectivo aleatorizado sobre el impacto del preacondicionamiento isquémico remoto sobre la nefropatía por contraste en pacientes intervenidos de reparación aórtica endovascular]]></article-title>
<article-title xml:lang="en"><![CDATA[Prospective randomized clinical trial on the impact of remote ischemic preconditioning on contrast induced nephropathy in patients treated endovascular aortic repair]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gutiérrez Castillo]]></surname>
<given-names><![CDATA[Diana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[San Norberto García]]></surname>
<given-names><![CDATA[Enrique M]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[del Río Solá]]></surname>
<given-names><![CDATA[Mª Lourdes]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Hospital Clínico Universitario de Valladolid  ]]></institution>
<addr-line><![CDATA[Valladolid ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2023</year>
</pub-date>
<volume>75</volume>
<numero>6</numero>
<fpage>362</fpage>
<lpage>372</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0003-31702023000600003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S0003-31702023000600003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S0003-31702023000600003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: el mayor inconveniente del uso de contrastes yodados en la práctica clínica es la nefropatía por contraste, que aumenta la morbimortalidad y los costes hospitalarios. El preacondicionamiento isquémico remoto (PCIR) es una técnica de protección tisular no invasiva que ha demostrado ser capaz de disminuir la afectación renal tras la administración de contraste intravascular.  Objetivo: el objetivo principal del estudio es valorar el impacto del PCIR en la incidencia de la nefropatía inducida por contraste en pacientes intervenidos de reparación aórtica endovascular (EVAR).  Material y métodos: se incluyeron pacientes intervenidos de EVAR electivo asignados de manera secuencial en grupo control y de preacondicionamiento (C y P, respectivamente). Se analizaron parámetros bioquímicos pre- y posoperatorios (a las 24 y a las 72 horas y a los 30 días).  Resultados: el 98,3 % de los pacientes incluidos en el estudio fueron varones, sobre una muestra total de 120 pacientes. La media de edad fue de 73 años (rango: 56-87). La diabetes y la insuficiencia renal crónica preoperatoria (entendida como filtrado glomerular &lt; 60 ml/min) estuvieron presentes en el 29,16 % y en el 38,33 % de los pacientes, respectivamente. La mitad de la muestra recibió preacondicionamiento en el preoperatorio. Un total de 24,17 % pacientes desarrollaron nefropatía a pesar de sueroterapia con o sin preacondicionamiento. En el posoperatorio (24-72 h) el preacondicionamiento no modificó la incidencia de nefropatía, creatinina y urea sérica o tasa de filtrado glomerular (eFG). Sin embargo, a los 30 días el grupo preacondicio-nado mostró una mejoría significativa de las cifras de creatinina y de ureas séricas (1,46 ± 0,3 frente a 1,03 ± 0,5; p &lt; 0,001; 61,06 ± 27,5 mg/dl frente a 43,78 ± 12,9 mg/dl; p = 0,003) y aumento de eFG (56,37 ± 23,4 ml/min /1,73 m2 frente a 72,85 ± 17,7ml/min/ 1,73 m2; p = 0,004).  Conclusiones: el PCIR parece efectivo en reducir los efectos del contraste yodado sobre el riñón en pacientes intervenidos de EVAR a corto plazo (30 días).]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: the biggest drawback of using iodinated contrasts in clinical practice is contrast nephropathy, which increases morbidity and mortality and hospital costs. Remote ischemic preconditioning (RIPC) is a non-invasive tissue protection technique that has proven to be able to reduce renal involvement after intravascular contrast administration.  Objective: the main goal of this study was to assess the impact of RIPC on the incidence of contrast-induced nephropathy in patients undergoing endovascular aortic repair (EVAR).  Material and methods: patients who underwent elective EVAR were included, and then sequentially assigned to the control and preconditioning groups (groups C and p, respectively). Pre- and postoperative hematocrit (at 24, 72 hours, and 30 days) was analyzed.  Results: a total of 98.3 % of the patients included in the study were men out of a total sample of 120 patients. The mean age was 73 years (range, 56-87). Diabetes and preoperative chronic kidney disease (understood as glomerular filtration rates &lt; 60 mL/min) were present in 29.16 % and 38.33 % of the patients, respectively. Half of the sample received preconditioning in the preoperative period. A total of 24.17 % of the patients developed nephropathy despite fluid therapy with or without preconditioning. At the postoperative period (24 h-72 h), preconditioning did not modify the incidence rate of nephropathy, serum creatinine and urea, or even the estimated glomerular filtration rate (eGFR). However, at the 30-day follow-up the preconditioned group showed a significant improvement in serum creatinine and urea levels (1.46 ± 0.3 vs 1.03 ± 0.5; p &lt; 0.001; 61.06 ± 27.5 mg/dL vs 43 .78 ± 12.9 mg/dL; p = 0.003) and eGFR increase (56.37 ± 23.4 mL/min/1.73 m2 vs 72.85 ± 17.7mL/min/1.73 m2; p = 0.004).  Conclusions: RIPC seems effective in alleviating the effects of iodinated contrast on the kidneys of patients undergoing EVAR in the short term follow up (30 days).]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[EVAR]]></kwd>
<kwd lng="es"><![CDATA[Preacondicionamiento isquémico remoto]]></kwd>
<kwd lng="es"><![CDATA[Nefropatía inducida por contraste]]></kwd>
<kwd lng="es"><![CDATA[Contraste intravascular]]></kwd>
<kwd lng="es"><![CDATA[Isquemia-reperfusión]]></kwd>
<kwd lng="en"><![CDATA[EVAR]]></kwd>
<kwd lng="en"><![CDATA[Remote ischemic preconditioning]]></kwd>
<kwd lng="en"><![CDATA[Contrast induced nephropathy]]></kwd>
<kwd lng="en"><![CDATA[Intravascular contrast media]]></kwd>
<kwd lng="en"><![CDATA[Ischemia-reperfusion injury]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saratzis]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Melas]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Mahmood]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence of Acute Kidney Injury (AKI) after Endovascular Abdominal Aortic Aneurysm Repair (EVAR) and Impact on Outcome]]></article-title>
<source><![CDATA[Eur J Vasc Endovasc Surg]]></source>
<year>2015</year>
<volume>49</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>534-40</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nicola]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Shaqdan]]></surname>
<given-names><![CDATA[KW]]></given-names>
</name>
<name>
<surname><![CDATA[Aran]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[ContrastInduced Nephropathy:Identifying the Risks, Choosing the Right Agent, and Reviewing Effective Prevention and Management Methods]]></article-title>
<source><![CDATA[Curr Probl Diagn Radiol]]></source>
<year>2015</year>
<volume>44</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>501-4</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[TT]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[UD]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[TI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions:insights from the NCDR CathPCI registry]]></article-title>
<source><![CDATA[JACC Cardiovasc Interv]]></source>
<year>2014</year>
<volume>7</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Azzalini]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Spagnoli]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ly]]></surname>
<given-names><![CDATA[HQ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contrast-Induced Nephropathy:From Pathophysiology to Preventive Strategies]]></article-title>
<source><![CDATA[Can J Cardiol]]></source>
<year>2016</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>247-55</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Owen]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hiremath]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Canadian Association of Radiologists consensus guidelines for the prevention of contrastinduced nephropathy:up-date 2012]]></article-title>
<source><![CDATA[Can Assoc Radiol J]]></source>
<year>2014</year>
<volume>65</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>96-105</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehta]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[SV]]></given-names>
</name>
</person-group>
<collab>Acute Kidney Injury Network</collab>
<article-title xml:lang=""><![CDATA[Acute Kidney Injury Network:report of an initiative to improve outcomes in acute kidney injury]]></article-title>
<source><![CDATA[Crit Care]]></source>
<year>2007</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>R31</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nash]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hafeez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hou]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hospital-acquired renal insufficiency]]></article-title>
<source><![CDATA[Am J Kidney Dis]]></source>
<year>2002</year>
<volume>39</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>930-6</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<collab>Sociedad Española de Nefrología</collab>
<source><![CDATA[Guías SEN:Actuación en el Fracaso Renal Agudo]]></source>
<year>2007</year>
<volume>27</volume>
<numero>Suppl.3</numero>
<issue>Suppl.3</issue>
<page-range>1-276</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Seeliger]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Sendeski]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rihal]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contrastinduced kidney injury:mechanisms, risk factors, and prevention]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2012</year>
<volume>33</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>2007-15</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kubota]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Remote ischemic preconditioning:Simple method but unknown mechanisms]]></article-title>
<source><![CDATA[J Cardiol]]></source>
<year>2016</year>
<volume>67</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>34-5</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gutiérrez Castillo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[San Norberto]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Fidalgo Domingos]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidência De Nefropatia Induzida Por Contraste Em Pacientes Operados De Reparação Aórtica Endovascular]]></article-title>
<source><![CDATA[Rev Port Cir Cardiotorac Vasc]]></source>
<year>2016</year>
<volume>22</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>101-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schilp]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[de Blok]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Langelaan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guideline adherence for identification and hydration of highrisk hospital patients for contrastinduced nephropathy]]></article-title>
<source><![CDATA[BMC Nephrol]]></source>
<year>2014</year>
<volume>15</volume>
<page-range>2</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Soni]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Ronco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Katz]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Early diagnosis of acute kidney injury:the promise of novel biomarkers]]></article-title>
<source><![CDATA[Blood Purif]]></source>
<year>2009</year>
<volume>28</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>165-74</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Boyle]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[TY]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Remote ischemic preconditioning for renal and cardiac protection during endovascular aneurysm repair:a randomized controlled trial]]></article-title>
<source><![CDATA[J Endovasc Ther]]></source>
<year>2009</year>
<volume>16</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>680-9</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stather]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Wych]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Boyle]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review and metaanalysis of remote ischemic preconditioning for vascular surgery]]></article-title>
<source><![CDATA[J Vasc Surg]]></source>
<year>2019</year>
<volume>70</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1353.e3-63.e3</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McDonald]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[McDonald]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Bida]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intravenous contrast materialinduced nephropathy:causal or coincident phenomenon?]]></article-title>
<source><![CDATA[Radiology]]></source>
<year>2013</year>
<volume>267</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>106-18</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Er]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Nia]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Dopp]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Ischemic preconditioning for prevention of contrast mediuminduced nephropathy:randomized pilot RenPro Trial (Renal Protection Trial)]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2012</year>
<volume>126</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>296-303</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mehran]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Aymong]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
<name>
<surname><![CDATA[Nikolsky]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A simple risk score for prediction of contrastinduced nephropathy after percutaneous coronary intervention:development and initial validation]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2004</year>
<volume>44</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1393-9</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sailer]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Nelemans]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[van Berlo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Endovascular treatment of complex aortic aneurysms:prevalence of acute kidney injury and effect on longterm renal function]]></article-title>
<source><![CDATA[Eur Radiol]]></source>
<year>2016</year>
<volume>26</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1613-9</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Healy]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Clarke-Moloney]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gaughan]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preconditioning Shields Against Vascular Events in Surgery (SAVES), a multicentre feasibility trial of preconditioning against adverse events in major vascular surgery:study protocol for a randomised control trial]]></article-title>
<source><![CDATA[Trials]]></source>
<year>2015</year>
<volume>16</volume>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mouton]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Pollock]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Soar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Remote ischaemic preconditioning versus sham procedure for abdominal aortic aneurysm repair:an external feasibility randomized controlled trial]]></article-title>
<source><![CDATA[Trials]]></source>
<year>2015</year>
<volume>16</volume>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[KN]]></given-names>
</name>
<name>
<surname><![CDATA[Cotter]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Repeated Episodes of Remote Ischemic Preconditioning for the Prevention of Myocardial Injury in Vascular Surgery]]></article-title>
<source><![CDATA[Vasc Endovascular Surg]]></source>
<year>2016</year>
<volume>50</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>140-6</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sadat]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Norden]]></surname>
<given-names><![CDATA[AG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Does oral N-acetylcysteine reduce contrast-induced renal injury in patients with peripheral arterial disease undergoing peripheral angiography?A randomizedcontrolled study]]></article-title>
<source><![CDATA[Angiology]]></source>
<year>2011</year>
<volume>62</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>225-30</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fox]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Symons]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Aviv]]></surname>
<given-names><![CDATA[RI]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Contrastinduced nephropathy and dehydration]]></article-title>
<source><![CDATA[Can Assoc Radiol J]]></source>
<year>2013</year>
<volume>64</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[RK]]></given-names>
</name>
<name>
<surname><![CDATA[Bang]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevention of Contrast-Induced Nephropathy (CIN) in Interventional Radiology Practice]]></article-title>
<source><![CDATA[Semin Intervent Radiol]]></source>
<year>2010</year>
<volume>27</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>348-59</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koch]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chaudru]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Lederlin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Remote Ischemic Preconditioning and Contrast-Induced Nephropathy:A Systematic Review]]></article-title>
<source><![CDATA[Ann Vasc Surg]]></source>
<year>2016</year>
<volume>32</volume>
<page-range>176-87</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Andreucci]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Faga]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Pisani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The ischemic/nephrotoxic acute kidney injury and the use of renal biomarkers in clinical practice]]></article-title>
<source><![CDATA[Eur J Intern Med]]></source>
<year>2017</year>
<volume>39</volume>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[D'Amore]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Nuzzo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Briguori]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biomarkers of Contrast-Induced Nephropathy:Which Ones are Clinically Important?Interv Cardiol Clin]]></article-title>
<source><![CDATA[]]></source>
<year>2020</year>
<volume>9</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>335-44</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rector]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Zakharova]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cardiac Remote Ischemic Preconditioning Prior to Elective Vascular Surgery (CRIPES):A Prospective, Randomized, Sham-Controlled Phase II Clinical Trial]]></article-title>
<source><![CDATA[J Am Heart Assoc]]></source>
<year>2016</year>
<volume>5</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Byun]]></surname>
<given-names><![CDATA[JY]]></given-names>
</name>
<name>
<surname><![CDATA[Kramers]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inducible nitricoxide synthase is an important contributor to prolonged protective effects of ischemic preconditioning in the mouse kidney]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>2003</year>
<volume>278</volume>
<numero>29</numero>
<issue>29</issue>
<page-range>27256-66</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heyman]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Leibowitz]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Mor-Yosef Levi]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Adaptive response to hypoxia and remote ischaemia preconditioning:a new hypoxiainducible factors era in clinical medicine]]></article-title>
<source><![CDATA[Acta Physiol (Oxf)]]></source>
<year>2016</year>
<volume>216</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>395-406</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<collab>Sociedad Española de Nefrología</collab>
<article-title xml:lang=""><![CDATA[Documento de la Sociedad Española de Nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica]]></article-title>
<source><![CDATA[Nefrología]]></source>
<year>2014</year>
<volume>34</volume>
<page-range>302-16</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bersani-Amado]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[da Rocha]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Schneider]]></surname>
<given-names><![CDATA[LCL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nephropathy induced by renal microembolism:a characterization of biochemical and histopathological changes in rats]]></article-title>
<source><![CDATA[Int J Clin Exp Pathol]]></source>
<year>2019</year>
<volume>12</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>2311-23</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stather]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Ferguson]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Awopetu]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Metaanalysis of Renal Function Following Infrarenal EVAR using Suprarenal or Infrarenal Fixation Devices]]></article-title>
<source><![CDATA[Eur J Vasc Endovasc Surg]]></source>
<year>2018</year>
<volume>56</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>486-96</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Tang]]></surname>
<given-names><![CDATA[TY]]></given-names>
</name>
<name>
<surname><![CDATA[Boyle]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Renal consequences of endovascular abdominal aortic aneurysm repair]]></article-title>
<source><![CDATA[J Endovasc Ther]]></source>
<year>2008</year>
<volume>15</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>73-82</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Twine]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Boyle]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Renal dysfunction after EVAR:time for a standard definition]]></article-title>
<source><![CDATA[J Endovasc Ther]]></source>
<year>2013</year>
<volume>20</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>331-3</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sen]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Tenorio]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Mirza]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of Blood Loss and Transfusion Requirements on Clinical Outcomes of Fenestrated-Branched Endovascular Aortic Repair]]></article-title>
<source><![CDATA[Cardiovasc Intervent Radiol]]></source>
<year>2020</year>
<volume>43</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1600-7</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[CC]]></given-names>
</name>
<name>
<surname><![CDATA[Tan]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Eckardt]]></surname>
<given-names><![CDATA[KU]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Erythropoietin production in rats with postischemic acute renal failure]]></article-title>
<source><![CDATA[Kidney Int]]></source>
<year>1996</year>
<volume>50</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1958-64</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zarbock]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kellum]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Van Aken]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Longterm Effects of Remote Ischemic Preconditioning on Kidney Function in Highrisk Cardiac Surgery Patients:Follow-up Results from the RenalRIP Trial]]></article-title>
<source><![CDATA[Anesthesiology]]></source>
<year>2017</year>
<volume>126</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>787-98</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
<name>
<surname><![CDATA[Nam]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[TK]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Sevoflurane, Propofol and Carvedilol Block Myocardial Protection by Limb Remote Ischemic Preconditioning]]></article-title>
<source><![CDATA[Int J Mol Sci]]></source>
<year>2019</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benstoem]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Goetzenich]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Stoppe]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of propofol for remote ischaemic preconditioning in the setting of cardiac surgery - a Cochrane systematic review]]></article-title>
<source><![CDATA[Br J Anaesth]]></source>
<year>2017</year>
<volume>119</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1234-5</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[CX]]></given-names>
</name>
<name>
<surname><![CDATA[Healy]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Walsh]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Remote preconditioning and cardiac surgery:regrouping after Remote Ischemic Preconditioning for Heart Surgery (RIPHeart) and Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Surgery (ERICCA)]]></article-title>
<source><![CDATA[J Thorac Dis]]></source>
<year>2016</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>E197-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
